West Pharmaceutical Services Inc. logo

West Pharmaceutical Services Inc. (WST)

Market Open
10 Jun, 13:56
NYSE NYSE
$
226. 71
+2.94
+1.31%
$
15.7B Market Cap
49.01 P/E Ratio
0.8% Div Yield
1,797 Volume
7.62 Eps
$ 223.77
Previous Close
Day Range
224.71 227.94
Year Range
187.43 352.33
Earnings results expected in 43 days

Summary

WST trading today higher at $226.71, an increase of 1.31% from yesterday's close, completing a monthly increase of 7.22% or $15.27. Over the past 12 months, WST stock lost -31.24%.
WST pays dividends to its shareholders, with the most recent payment made on May 07, 2025. The next announced payment will be in In 1 month on Aug 06, 2025 for a total of $0.21.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.15%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
West Pharmaceutical Services Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track WST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

WST Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors – Contact Levi & Korsinsky Before July 7, 2025

Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors – Contact Levi & Korsinsky Before July 7, 2025

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accessnewswire | 2 hours ago
WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

Accessnewswire | 3 hours ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST

NEW YORK , June 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.

Prnewswire | 4 hours ago

West Pharmaceutical Services Inc. Dividends

West Pharmaceutical Services Inc. logo
WST In 1 month
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 1 month ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 4 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 6 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 10 months ago
Paid
Quarterly
$0.2 Per Share

West Pharmaceutical Services Inc. Earnings

23 Jul 2025 (43 Days) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS
West Pharmaceutical Services Inc. logo
WST In 1 month
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 1 month ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 4 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 6 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 10 months ago
Paid
Quarterly
$0.2 Per Share
23 Jul 2025 (43 Days) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS

West Pharmaceutical Services Inc. (WST) FAQ

What is the stock price today?

The current price is $226.71.

On which exchange is it traded?

West Pharmaceutical Services Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is WST.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 15.7B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has West Pharmaceutical Services Inc. ever had a stock split?

West Pharmaceutical Services Inc. had 4 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Mr. Eric M. Green CEO
NYSE Exchange
955306105 Cusip
US Country
10,600 Employees
30 Apr 2025 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900